Tower Research Capital LLC (Trc) Pfizer Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Pfizer Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 246,674 shares of PFE stock, worth $6.6 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

246,674

Previous 179,956 37.07%

Holding current value

$6.6 Million

Previous $5.04 Million 41.77%

% of portfolio

0.19%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $1.85 Million - $2.09 Million	66,718 Added 37.07%	246,674 $7.14 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $1.98 Million - $2.33 Million	78,576 Added 77.51%	179,956 $5.04 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $15.6 Million - $18 Million	-604,099 Reduced 85.63%	101,380 $2.81 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $13.6 Million - $17.7 Million	521,677 Added 283.83%	705,479 $20.3 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $2.92 Million - $3.41 Million	90,896 Added 97.84%	183,802 $6.1 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $4,370 - $5,056	121 Added 0.13%	92,906 $3.41 Million
Q1 2023 May 09, 2023	SELL	$39.39 - $51.28 $21,940 - $28,562	-557 Reduced 0.6%	92,785 $3.79 Million
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $16 Million - $20.9 Million	-383,129 Reduced 80.41%	93,342 $4.78 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $8.92 Million - $10.9 Million	203,813 Added 74.75%	476,471 $20.9 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $22.5 Million - $26.7 Million	-484,586 Reduced 63.99%	272,658 $14.3 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $19.3 Million - $23.9 Million	421,347 Added 125.44%	757,244 $39.2 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $8.61 Million - $12.8 Million	208,335 Added 163.32%	335,897 $19.8 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $6.82 Million - $8.77 Million	-173,877 Reduced 57.68%	127,562 $5.49 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $8.43 Million - $9.55 Million	-234,731 Reduced 43.78%	301,439 $11.8 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $12.8 Million - $14.4 Million	381,362 Added 246.35%	536,170 $19.4 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $2.05 Million - $2.6 Million	61,112 Added 65.22%	154,808 $5.7 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $219,043 - $256,987	6,899 Added 7.95%	93,696 $3.44 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $2.61 Million - $3.17 Million	86,797 New	86,797 $2.84 Million
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $5.05 Million - $5.73 Million	-153,382 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$32.49 - $42.13 $3.28 Million - $4.25 Million	100,976 Added 192.68%	153,382 $5.51 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $1.76 Million - $1.98 Million	-47,627 Reduced 47.61%	52,406 $2.27 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $563,512 - $619,112	-15,027 Reduced 13.06%	100,033 $4.25 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $2.72 Million - $3.1 Million	70,779 Added 159.84%	115,060 $5.02 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $5.61 Million - $6.81 Million	-162,856 Reduced 78.62%	44,281 $1.95 Million
Q2 2018 Aug 15, 2018	BUY	$32.98 - $35.16 $6.8 Million - $7.25 Million	206,337 Added 25792.13%	207,137 $7.52 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $1.44 Million - $1.67 Million	-45,146 Reduced 98.26%	800 $28,000
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $1.52 Million - $1.61 Million	45,746 Added 22873.0%	45,946 $1.67 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $6,200 - $6,830	200	200 $7,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Pfizer Inc Transaction History